1.24
+0.01(+0.81%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1183
First IPO Date
July 11, 2003
| Name | Title | Pay | Year Born |
| Ms. Liwei Yu | Chief Executive Officer | 2.16M | 1971 |
| Mr. Yung Lai Hung | Co-Founder & Executive Director | 701,916 | 1944 |
| Ms. Kei Ling Li | Co-Founder & Executive Chairman | 1.17M | 1949 |
| Mr. Yi Jun Wu | Chief Financial Officer | 0 | 1964 |
| Ms. Kit Ling Pang CPA | Company Secretary | 0 | 1966 |
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.